Doctor Says Info Martoma Had Wasn't Secret

Jan 31 2014 | 12:42pm ET

Former SAC Capital Advisors portfolio manager Mathew Martoma's defense against insider trading charges closed with the claim that the information he allegedly traded on wasn't insider at all.

Thomas Wisniewski, a medical professor at New York University, testified yesterday that a PowerPoint presentation sent by the government's star witness to Martoma contained the same information, by and large, as an earlier press release about the Alzheimer's drug trial in question. That would mean Martoma did nothing wrong if he had traded on the information he received from Sidney Gilman, a doctor overseeing the trial.

Gilman said he sent Martoma his presentation a week before the data it contained was made public.

Martoma is accused of earning or saving SAC $276 million trading shares of the pharmaceutical companies that developed the drug, Elan Corp. and Wyeth LLC. If convicted, he faces decades in prison.

Under cross-examination, Wisniewski said his analysis was only his personal opinion, and not undisputed medical fact.

Martoma's legal team rested yesterday, setting the stage for closing arguments to begin on Monday.


In Depth

FINalternatives Survey: We Asked Investment Pros...

Apr 2 2016 | 9:42pm ET

The data from our annual reader survey continues to roll in and provide interesting...

Lifestyle

Point72's Cohen Donates $275M To Veterans Mental Health Network

Apr 6 2016 | 8:31pm ET

Billionaire hedge fund manager Steve Cohen has formed a non-profit aimed at treating...

Guest Contributor

Agecroft: Why NYCERS Should Reconsider Exiting All Hedge Funds

Apr 18 2016 | 5:51pm ET

The recent decision by the New York City Employment Retirement System to exit its...